ArrowMark Colorado Holdings LLC
- SEC CIK
- 0001483859
- Latest filing
- Aug 13, 2026
The latest 13F from ArrowMark Colorado Holdings LLC covers Q2 2026 (filed Aug 13, 2026): 296 long positions worth $2.40B. The top 10 holdings make up 15.3% of the portfolio, and the largest is State Street SPDR Bloomberg 1-3 Month T-Bill ETF at 3.7%. Livermore has 23 filings on Form 13F from this institution, going back to Q1 2021.
What changed in Q2 2026
Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 29
- Est. +$158.2M
- Added
- 32
- Est. +$65.0M
- Reduced
- 159
- Est. −$2.14B
- Sold out
- 26
- Est. −$180.7M
Top 5 holdings
Share of this quarter's portfolio value
Biggest buys
New and added positions, by estimated amount bought
Largest weight increases
New and added positions, by percentage points of the portfolio gained
Biggest sells
Reduced and sold-out positions, by estimated amount sold
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
Metrics
13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $2.40B
- −$1.36B (−36.2%) vs. prior quarter
- Positions
- 296
- +3 vs. prior quarter
- Top 10 concentration
- 15.3%
- Top 10 as share of value
- Turnover
- 7.2%
- Q2 2026, one quarter
- Average holding period
- 11.2 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.
13F filings by quarter
22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $13.4B (Q1 2021)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | 296 | $2.40B | State Street SPDR Bloomberg 1-3 Month T-Bill ETFMGMVST | vs. Q1 2026 | SEC |
| Q1 2026 | May 15, 2026 | 293 | $3.76B | State Street SPDR Bloomberg 1-3 Month T-Bill ETFFSSTRMB | vs. Q4 2025 | SEC |
| Q4 2025 | Feb 17, 2026 | 309 | $4.54B | State Street SPDR Bloomberg 1-3 Month T-Bill ETFTPBTRMB | vs. Q3 2025 | SEC |
| Q3 2025 | Nov 14, 2025 | 303 | $5.38B | State Street SPDR Bloomberg 1-3 Month T-Bill ETFTRMBCARG | vs. Q2 2025 | SEC |
| Q2 2025 | Aug 14, 2025 | 301 | $5.55B | CARGRBATRMB | vs. Q1 2025 | SEC |
| Q1 2025 | May 15, 2025 | 298 | $6.17B | RBACARGCHDN | vs. Q4 2024 | SEC |
| Q4 2024 | Feb 14, 2025 | 306 | $7.44B | RBACARGCHDN | vs. Q3 2024 | SEC |
| Q3 2024 | Nov 14, 2024 | 301 | $7.81B | RBASMARTRMB | vs. Q2 2024 | SEC |
| Q2 2024 | Aug 14, 2024 | 312 | $8.39B | RBAACVATRMB | vs. Q1 2024 | SEC |
| Q1 2024 | May 15, 2024 | 317 | $8.79B | RBATRMBALIT | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 14, 2024 | 307 | $9.06B | ALITRBAZD | vs. Q3 2023 | SEC |
| Q3 2023 | Nov 14, 2023 | 307 | $8.22B | RBAQDELALIT | vs. Q2 2023 | SEC |
| Q2 2023 | Aug 14, 2023 | 302 | $9.11B | RBAQDELALIT | vs. Q1 2023 | SEC |
| Q1 2023 | May 15, 2023 | 305 | $8.80B | QDELRBAALIT | vs. Q4 2022 | SEC |
| Q4 2022 | Feb 14, 2023 | 304 | $8.38B | QDELRBAALIT | vs. Q3 2022 | SEC |
| Q3 2022 | Nov 14, 2022 | 328 | $8.15B | RBAFTDRQDEL | vs. Q2 2022 | SEC |
| Q2 2022 | Aug 15, 2022 | 325 | $8.74B | FTDRRBASKX | vs. Q1 2022 | SEC |
| Q1 2022 | May 16, 2022 | 342 | $11.4B | SKXMATXFTDR | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 14, 2022 | 334 | $12.4B | SKXMATXSTE | vs. Q3 2021 | SEC |
| Q3 2021 | Nov 17, 2021Amended | 356 | $12.8B | MATXZDON | vs. Q2 2021 | SECSEC |
| Q2 2021 | Aug 16, 2021 | 343 | $13.3B | SKXZDSBH | vs. Q1 2021 | SEC |
| Q1 2021 | May 17, 2021 | 345 | $13.4B | SKXSBHZD | – | SEC |
13D and 13G filings
Companies where ArrowMark Colorado Holdings LLC reports owning 5% or more on Schedule 13D or 13G, and its latest filings.
Current stakes of 5% or more
1 company, largest stake first.
Latest filings
227 filings on file made by ArrowMark Colorado Holdings LLC or listing it as a reporting person; the latest 20 are shown.
| Company | Filed (ET) | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| PMVPPMV Pharmaceuticals, Inc. | Jul 10, 202611:40 AM ET | 13G/A | 3.67%1.96M shares | −2.14 ppfrom 5.81%Below 5% | Jun 30, 2026 | SEC |
| CCSIConsensus Cloud Solutions, Inc. | Apr 10, 20269:57 AM ET | 13G/A | 1.97%371.1K shares | −4.19 ppfrom 6.16%Below 5% | Mar 31, 2026 | SEC |
| SPTSprout Social, Inc. | Apr 10, 20269:55 AM ET | 13G/A | 1.14%611.8K shares | −5.84 ppfrom 6.98%Below 5% | Mar 31, 2026 | SEC |
| BANXArrowMark Financial Corp. | Apr 10, 20269:54 AM ET | 13G/A | 9.14%884.8K shares | −1.21 ppfrom 10.35% | Mar 31, 2026 | SEC |
| ZIPZiprecruiter, Inc. | Feb 17, 20264:38 PM ET | 13G/A | 2.79%2.02M shares | −2.48 ppfrom 5.27%Below 5% | Dec 31, 2025 | SEC |
| ZDZiff Davis, Inc. | Feb 17, 20264:37 PM ET | 13G/A | 3.46%1.37M shares | −1.61 ppfrom 5.07%Below 5% | Dec 31, 2025 | SEC |
| TNDMTandem Diabetes Care Inc | Feb 17, 20264:37 PM ET | 13G/A | 4.26%2.89M shares | −1.20 ppfrom 5.46%Below 5% | Dec 31, 2025 | SEC |
| SPTSprout Social, Inc. | Feb 17, 20264:36 PM ET | 13G/A | 6.98%3.71M shares | −1.31 ppfrom 8.29% | Dec 31, 2025 | SEC |
| PMVPPMV Pharmaceuticals, Inc. | Feb 17, 20264:36 PM ET | 13G/A | 5.81%3.09M shares | – | Dec 31, 2025 | SEC |
| CMPRCIMPRESS plc | Feb 17, 20264:35 PM ET | 13G/A | 3.58%883.0K shares | −1.56 ppfrom 5.14%Below 5% | Dec 31, 2025 | SEC |
| CCSIConsensus Cloud Solutions, Inc. | Feb 17, 20264:34 PM ET | 13G/A | 6.16%1.17M shares | −2.52 ppfrom 8.68% | Dec 31, 2025 | SEC |
| BANXArrowMark Financial Corp. | Jan 15, 202610:52 AM ET | 13G | 10.35%808.1K shares | – | Dec 31, 2025 | SEC |
| CMPRCIMPRESS plc | Nov 13, 20259:08 AM ET | 13G | 5.14%1.26M shares | – | Sep 30, 2025 | SEC |
| CCSIConsensus Cloud Solutions, Inc. | Nov 13, 20259:05 AM ET | 13G/A | 8.68%1.65M shares | – | Sep 30, 2025 | SEC |
| TNDMTandem Diabetes Care Inc | Nov 13, 20259:01 AM ET | 13G | 5.46%3.69M shares | New | Sep 30, 2025 | SEC |
| ZIPZiprecruiter, Inc. | Oct 23, 202510:39 AM ET | 13G/A | 5.27%4.21M shares | – | Jun 30, 2025 | SEC |
| ZDZiff Davis, Inc. | Oct 23, 202510:38 AM ET | 13G/A | 5.07%2.13M shares | – | Jun 30, 2025 | SEC |
| SPTSprout Social, Inc. | Oct 23, 202510:37 AM ET | 13G/A | 8.29%4.30M shares | +1.73 ppfrom 6.56% | Jun 30, 2025 | SEC |
| EGHT8X8 Inc | Oct 23, 202510:35 AM ET | 13G/A | 1.93%2.60M shares | −6.20 ppfrom 8.13%Below 5% | Jun 30, 2025 | SEC |
| CARGCarGurus, Inc. | Oct 23, 202510:34 AM ET | 13G/A | 4.42%3.74M shares | −1.40 ppfrom 5.82%Below 5% | Jun 30, 2025 | SEC |